Voya Investment Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $36,840 - $65,801	-21,295 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $8,217 - $13,332	2,795 Added 15.11%	21,295 $63,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $1,530 - $1,992	-376 Reduced 1.99%	18,500 $83,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $10.93 $9,997 - $16,045	-1,468 Reduced 7.22%	18,876 $129,000
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $26,843 - $41,847	5,861 Added 40.47%	20,344 $127,000
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $8,036 - $14,125	-2,706 Reduced 15.74%	14,483 $76,000
Q1 2020 May 15, 2020	SELL	$2.67 - $4.97 $5,211 - $9,701	-1,952 Reduced 10.2%	17,189 $54,000
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $17,547 - $26,950	5,989 Added 45.54%	19,141 $77,000
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $26,305 - $35,848	2,579 Added 24.39%	13,152 $134,000
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $199,829 - $298,158	10,573	10,573 $265,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.